H.R. 8083

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8083 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 8083

To allow women greater access to safe and effective oral contraceptive 
drugs intended for routine use, and to direct the Comptroller General 
of the United States to conduct a study on Federal funding of 
contraceptive methods.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 25, 2026

Mrs. Hinson (for herself, Mrs. Miller-Meeks, Mr. Nunn of Iowa, and Mr. 
Ciscomani) introduced the following bill; which was referred to the 
Committee on Energy and Commerce, and in addition to the Committees on 
Ways and Means, Natural Resources, and Armed Services, for a period to 
be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
committee concerned

_______________________________________________________________________

A BILL

To allow women greater access to safe and effective oral contraceptive 
drugs intended for routine use, and to direct the Comptroller General 
of the United States to conduct a study on Federal funding of 
contraceptive methods.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Allowing Greater Access to Safe and 
Effective Contraception Act''.

SEC. 2. SUPPLEMENTAL APPLICATIONS FOR OVER-THE-COUNTER CONTRACEPTIVE 
DRUGS.

(a) Priority Review of Application.--The Secretary of Health and 
Human Services (referred to in this section as the ``Secretary'') shall 
give priority review to any supplemental application submitted under 
section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
355(b)) if--
(1) the supplemental application is with respect to an oral 
contraceptive drug intended for routine use;
(2) the supplemental application is not with respect to--
(A) any emergency contraceptive drug; or
(B) any drug that is also approved for induced 
abortion; and
(3) if the supplemental application is approved, with 
respect to individuals aged 18 and older, such drug would not 
be subject to section 503(b)(1) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 353(b)(1)).
(b) Fee Waiver.--The Secretary shall waive the fee under section 
736(a)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379h(a)(1)) with respect to a supplemental application that receives 
priority review under subsection (a).
(c) Over-the-Counter Availability.--Notwithstanding any other 
provision of law, with respect to individuals under age 18, a 
contraceptive drug that is eligible for priority review under 
subsection (a) shall be subject to section 503(b)(1) of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1)), including after 
approval of the supplemental application as described in subsection 
(a)(3).
(d) Applicability.--This section applies with respect to a 
supplemental application described in subsection (a) that--
(1) is submitted before the date of enactment of this Act 
and remains pending as of such date of enactment; or
(2) is submitted after such date of enactment.

SEC. 3. GAO STUDY AND REPORT ON FEDERAL FUNDING OF CONTRACEPTIVE 
METHODS.

Not later than one year after the date of enactment of this Act, 
the Comptroller General of the United States shall conduct a study and 
submit a report to Congress regarding the amount of Federal funds made 
available for the purposes of contraception reimbursement, inventory 
stocking, provider training, or patient education during the 15-year 
period immediately preceding such date of enactment, including such 
funding made available through--
(1) the Medicare program under title XVIII of the Social 
Security Act (42 U.S.C. 1395 et seq.);
(2) the Medicaid program under title XIX of the Social 
Security Act (42 U.S.C. 1396 et seq.);
(3) the Indian Health Service;
(4) the American Health Benefit Exchanges established under 
section 1311 or 1321 of the Patient Protection and Affordable 
Care Act (42 U.S.C. 18031; 18041);
(5) Federally-qualified health centers (as defined in 
section 1905(l)(2)(B) of the Social Security Act (42 U.S.C. 
1396d(l)(2)(B)));
(6) title X of the Public Health Service Act (42 U.S.C. 300 
et seq.);
(7) temporary assistance for needy families under part A of 
title IV of the Social Security Act (42 U.S.C. 601 et seq.); or
(8) the TRICARE program (as defined in section 1072 of 
title 10, United States Code).
<all>